Stock Insiders: Bone healing company Osteopore is regenerating bones with 3D-printed scaffold system

Stock Insiders is a new podcast series focussed on investing hosted by renowned business journalist Oriel Morrison. The program is sponsored by Barclay Pearce Capital, Australia’s leading corporate advisory and equities trading firm.

In this episode Oriel chats to Mark Leong, Executive Chairman at Osteopore (ASX:OSX).

Osteopore is involved in designing, developing and marketing bioresorbable polymer implants for neurosurgical, orthopaedic, and maxillofacial surgery use.

The company specialises in the production of 3D printed bioresorbable implants that are used in conjunction with surgical procedures to assist with the natural stages of bone healing.

Osteopore recently announced they will work with medical tech firm Singular Health (ASX:SHG) to improve the accuracy and workflow efficiency of its ground-breaking cranial implants.

To hear more about Mark’s introduction to Osteopore, the company’s patent grant in China and more, click below.